HAPPE Spine Reaches 1,000 Patients with the INTEGRATE®-C Interbody Fusion System
GRAND RAPIDS, Mich., Nov. 13, 2025 /PRNewswire/ — HAPPE Spine, an early stage company advancing clinical outcomes with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more... Read More →
Augmedics wins FDA clearance for next-gen AR headset for use with Xvision Spine System
Augmedics announced today that it received FDA 510(k) clearance for X2, its next-generation augmented reality (AR) headset. X2 works with the company’s Xvision Spine System, which uses AR to give surgeons “X-ray vision” during surgery. The system superimposes critical data... Read More →
Laronix Secures $3.2 Million Grant from the Australian Government to Bring its AI-Powered Voice Technology to the Market
BRISBANE, Australia, Nov. 12, 2025 /PRNewswire/ — Laronix, (“Laronix” or the “Company”), a commercial-stage medical technology (MedTech) company and an industry-leading innovator in voice restoration technologies, today announced that it has been awarded AUD $3.2 million (approximately USD $2.1 million)... Read More →
California Association of Health Facilities (CAHF) Selects Darmiyan as Preferred Provider for Cognitive Health Solutions
SAN FRANCISCO, Nov. 6, 2025 /PRNewswire/ — The California Association of Health Facilities (CAHF) has selected Darmiyan, Inc., a leading neurotechnology company, as its only Preferred Provider for Cognitive Health Solutions. Through this partnership, more than 1,300 CAHF member facilities,... Read More →
Nitinotes Receives CE Mark Approval of EndoZip™, the First Fully Automated Suturing System for Endoscopic Sleeve Gastroplasty
CAESAREA, Israel, Nov. 6, 2025 /PRNewswire/ — Nitinotes Ltd., a medical device company transforming the treatment of obesity, today announced it has received CE Mark approval for the EndoZip™ System, the first fully automated suturing platform for endoscopic sleeve gastroplasty... Read More →
ATDev Joins $41 Million ARPA-H Initiative to Build the Future of Robotic Mobility and Independence
PITTSBURGH, Nov. 6, 2025 /PRNewswire/ — Assistive Technology Development, Inc. (ATDev) announced today that it is a subcontractor for the Robotic Assistive Mobility and Manipulation Platform (RAMMP) program, awarded to the University of Pittsburgh under the Advanced Research Projects Agency... Read More →
Biotome Secures $498K to Advance Preeclampsia Diagnostic
Perth biotech, Biotome, awarded prestigious Future Health Research and Innovation (FHRI) Fund Innovation Seed Fund grant to develop a first-trimester blood test that could prevent hundreds of preeclampsia cases annually in Western Australia and thousands worldwide. Addressing a Critical Gap... Read More →
FDA Greenlights Pivotal Study of PRECISIS’ Minimally Invasive Brain-Stimulation Therapy for Drug-Resistant Epilepsy
Heidelberg, Germany – November 6, 2025. PRECISIS GmbH today announced that the U.S. Food & Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval for its pivotal EASEE4US clinical study, marking a significant step toward U.S. market entry for... Read More →
Aqua Medical wins FDA IDE to launch trial for ablation procedure that treats diabetes
Aqua Medical has received an investigational device exemption (IDE) from the FDA for its ablation device intended to treat diabetes, the company told MassDevice ahead of an official announcement later today. The IDE gives the device developer the green light... Read More →
Multiphze Receives Innovative Technology Contract from Vizient
Glendale, CA, November 4, 2025 – Multiphze, LLC is announcing that the MultiphzeÒ Enclosed Bladder Irrigation System has received an Innovative Technology contract from Vizient® the nation’s largest provider-driven healthcare performance improvement company. The contract was awarded based on review... Read More →